Fosfomycin: Clinical Trials

7 trials of Fosfomycin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown. 7 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 5, Unknown 2
Phase 22Completed 1, Unknown 1

Follow Fosfomycin: new trials by email Literature Review of Fosfomycin trials Research Report on Fosfomycin

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness of Single Dose Fosfomycin and Single Dose Levofloxacin as Pre-urodynamic Antibiotic for UTI Prevention
Fosfomycin 3000 MG, Levofloxacin 500mg - Urological System Complication of Procedure, Urinary Tract Infections
Phase 1 / Phase 2CompletedUniversitas Indonesia1262022-12-302024-10-09
GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery
GM-CSF, fosfomycin and metronidazole - Pouchitis
Phase 1 / Phase 2UnknownZealand University Hospital182021-09-062023-01-26
PK Study of Single-Dose ZTI-01 in Children (<12 Years of Age)
ZTI-01 100 mg/kg, ZTI-01 75 mg/kg - Pediatric ALL
Phase 1UnknownNabriva Therapeutics AG212018-05-242023-09-15
4-way Crossover QT Evaluation in Healthy Subjects
ZTI-01, Moxifloxacin 400mg, Placebo IV - Cardiac Repolarization in Healthy Subjects
Phase 1CompletedNabriva Therapeutics AG412018-01-112019-03-06
Open-Label Phase 1 Study of Aerosolized Amikacin and Fosfomycin in Healthy Volunteers
amikacin/fosfomycin - Healthy
Phase 1CompletedCardeas Pharma302016-04-012016-07-11
PK/PD and Safety/Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adults
Fosfomycin - Healthy Subjects
Phase 1CompletedVance Fowler, M.D.192016-01-012019-07-30
Safety, Tolerability and PK 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and MonurolĀ® in Healthy Subjects
Fosfomycin tromethamine, Fosfomycin disodium - Pseudomonas Infection
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)302014-08-012016-04-04

Conditions studied

Pouchitis (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Pseudomonas Infections (1)  ·  Urinary Tract Infections (1)

Sponsors

Nabriva Therapeutics AG (2)  ·  Cardeas Pharma (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Universitas Indonesia (1)  ·  Vance Fowler, M.D. (1)  ·  Zealand University Hospital (1)

Countries

United States (5)  ·  Denmark (1)  ·  Indonesia (1)

Top investigators

Evelyn J Ellis-Grosse, PhD (1)  ·  Harrina E Rahardjo, Professor (1)  ·  Jennifer Schranz, MD (1)  ·  John S Bradley, MD (1)  ·  Vance Fowler, MD (1)

Results publications

PMID 29891606, PMID 31767717, PMID 40660169, PMID 42728546

NIH funding

1UM1AI104681-01 (1)